182 related articles for article (PubMed ID: 30791442)
1. Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014.
Bissell K; Ellwood P; Ellwood E; Chiang CY; Marks GB; El Sony A; Asher I; Billo N; Perrin C;
Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30791442
[TBL] [Abstract][Full Text] [Related]
2. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar ZU; Lessing C; Mace C; Bissell K
Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
[TBL] [Abstract][Full Text] [Related]
3. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
4. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.
Stolbrink M; Thomson H; Hadfield RM; Ozoh OB; Nantanda R; Jayasooriya S; Allwood B; Halpin DMG; Salvi S; de Oca MM; Mortimer K; Rylance S
Lancet Glob Health; 2022 Oct; 10(10):e1423-e1442. PubMed ID: 36113528
[TBL] [Abstract][Full Text] [Related]
5. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
6. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
7. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
8. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
9. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
[TBL] [Abstract][Full Text] [Related]
10. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
11. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
12. Asthma management in low and middle income countries: case for change.
Mortimer K; Reddel HK; Pitrez PM; Bateman ED
Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 35210321
[TBL] [Abstract][Full Text] [Related]
13. Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective.
Kibirige D; Kampiire L; Atuhe D; Mwebaze R; Katagira W; Muttamba W; Nantanda R; Worodria W; Kirenga B
BMC Pulm Med; 2017 Dec; 17(1):179. PubMed ID: 29216852
[TBL] [Abstract][Full Text] [Related]
14. Access and use of WHO essential medicines in Italy.
Petrella A; Fortinguerra F; Cangini A; Pierantozzi A; Trotta F
Front Public Health; 2023; 11():1211208. PubMed ID: 37881343
[TBL] [Abstract][Full Text] [Related]
15. Essential medicines for COPD and asthma in low and middle-income countries.
Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
Thorax; 2014 Dec; 69(12):1149-51. PubMed ID: 24590803
[TBL] [Abstract][Full Text] [Related]
16. Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites.
Gnatiuc L; Buist AS; Kato B; Janson C; Aït-Khaled N; Nielsen R; Koul PA; Nizankowska-Mogilnicka E; Obaseki D; Idolor LF; Harrabi I; Burney PG;
Int J Tuberc Lung Dis; 2015 Jan; 19(1):21-30. PubMed ID: 25519786
[TBL] [Abstract][Full Text] [Related]
17. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
[TBL] [Abstract][Full Text] [Related]
18. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
19. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]